Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors.
Haghnejad V, Muller M, Blaise L, Gerolami R, Bouattour M, Assenat E, Manfredi S, Peron JM, Burcheri-Curatolo A, Lopez A, Ressiot E, Nahon P, Bronowicki JP.
Haghnejad V, et al. Among authors: gerolami r.
Dig Liver Dis. 2023 Jul;55(7):938-944. doi: 10.1016/j.dld.2023.03.005. Epub 2023 Apr 3.
Dig Liver Dis. 2023.
PMID: 37019737